BackProtagenic Therapeutics Overview

Protagenic Therapeutics Research & Development

Research & Development expenses for PTIX.

Quarterly R&D Expenses

$153786.00
↓ 82.98% YoY

As of Dec 31, 2025

Annual R&D Expenses (TTM)

$1.70M
↓ 56.2% YoY

Trailing 12 months ending Dec 31, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin